共 189 条
[1]
Rhodes A(2016)Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016 Intensive Care Med 43 304-377
[2]
Evans LE(2012)Terlipressin in the treatment of late phase catecholamine-resistant septic shock Hepatogastroenterology 59 1043-1047
[3]
Alhazzani W(2006)Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions Crit Care Med 34 1126-1130
[4]
Levy MM(2012)Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study Intensive Care Med 38 950-958
[5]
Antonelli M(2010)Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial Intensive Care Med 36 57-503
[6]
Ferrer R(2008)Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 358 877-19
[7]
Kumar A(2015)Exogenous vasopressin-induced hyponatremia in patients with vasodilatory shock: two case reports and literature review J Intensive Care Med 30 253-1902
[8]
Sevransky JE(2008)Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study Br J Anaesth 100 494-517
[9]
Sprung CL(2009)Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study Crit Care 13 R130-394
[10]
Nunnally ME(2012)Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials Crit Care 16 R154-406